Mr. Huffines joined J.P. Morgan in 1991 in the Mergers and Acquisitions group, focusing on healthcare. From 2002 – 2010. He was co-head of the global healthcare investment banking group. In 2011, he was promoted to Vice Chairman, and in 2017 he was added to the Global Banking management team and named Co-Chair of the Global Strategic Advisory Council. Prior to joining J.P. Morgan, Robbie worked at Alex Brown & Sons, specializing in equity financing and advisory assignments for emerging growth companies. Mr. Huffines is a member of the Entrepreneurship Minor Committee, Center for the Business of Healthcare and Board of Visitors at the University of North Carolina, and also serving as a Board Member of the Spence School, the Darden School at the University of Virginia, and the Hastings Center for Biomedical Ethics. Robbie is also a member of the Nextech Invest Ltd. board, a cancer-focused venture capital firm headquartered in Zurich, Switzerland.
Personal Details
Title: Mr
Surname: Huffines
Known as: Robbie
M/F: Male
Nationality: United States of America
Country of Birth: United States of America
Language: English
Qualification: Not Available
Industry:
Qualifications & Experience
Industry Experience +5yrs:
Industry Qualification +5yrs?:
Finance experience +5yrs?:
Finance Qualification +5yrs:
Legal experience +5yrs?:
Delinquent director?:
Other Experiences?:
Collapsed company director?:
Other directorships (state)
(only entities turnover at least $5m p/a)
Working history
Committee/s
Company
Committee
Role
Appointment Date
Resignation Date
Walgreens
Board
Member
Independence Questions
Any family members working for the company?:
Are you doing business with the company?:
Do you hold shares in the company for more than 0.10%? (directly or by representation):
Is your Director annual fee more than 5% of your total income from all sources?:
Are you more than 10 years as a director?:
Are you an executive chairperson?:
InsidEntity has assumed that responses to the Independent Questions are NO as the company has not populated the information. The result will present the Director as Independent.